Ethnic diversity in genetic study identifies more genomic regions linked to type 2 diabetes-related traits

By ensuring ethnic diversity in a largescale genetic study, an international team of researchers, including a University of Massachusetts Amherst genetic epidemiologist, has identified more regions of the genome linked to type 2 diabetes-related traits.

The findings, published May 31 in Nature Genetics, broaden the understanding of the biological basis of type 2 diabetes and demonstrate that expanding research into different ancestries yields better results. Ultimately the goal is to improve patient care worldwide by identifying genetic targets to treat the chronic metabolic disorder. Type 2 diabetes affects and sometimes debilitates more than 460 million adults worldwide, according to the International Diabetes Federation. About 1.5 million deaths were directly caused by diabetes in 2019, the World Health Organization reports.

Cassandra Spracklen, assistant professor of biostatistics and epidemiology in the UMass Amherst School of Public Health and Health Sciences, is part of the international MAGIC collaboration. That group of more than 400 global academics conducted the genome-wide association meta-analysis, led by the University of Exeter in the United Kingdom.

"Our findings matter because we're moving toward using genetic scores to weigh up a person's risk of diabetes," says Spracklen, one of the paper's lead authors.

Up to now, some 88% of genomic research of this type has been conducted in white European-ancestry populations. "We know that scores developed exclusively in individuals of one ancestry don't work well in people of a different ancestry," Spracklen adds.

The team analyzed data across a wide range of cohorts, encompassing more than 280,000 people without diabetes. Researchers looked at glycemic traits, which are used to diagnose diabetes and monitor sugar and insulin levels in the blood.

The researchers incorporated 30 percent of the overall cohort with individuals of East Asian, Hispanic, African-American, South Asian and sub-Saharan African origin. By doing so, they discovered 24 more loci - or regions of the genome - linked to glycemic traits than if they had conducted the research in Europeans alone.

"Type 2 diabetes is an increasingly huge global health challenge- with most of the biggest increases occurring outside of Europe," says Inês Barroso, professor of diabetes at the University of Exeter, who led the research. "While there are a lot of shared genetic factors between different countries and cultures, our research tells us that they do differ in ways that we need to understand. It's critical to ensuring we can deliver a precision diabetes medicine approach that optimizes treatment and care for everyone."

Beyond the moral arguments for ensuring research is reflective of global populations, our work demonstrates that this approach generates better results."

Ji Chen, First Author, Data Science Expert, University of Exeter

Though some loci were not detected in all ancestries, the team found it is useful to capture information about the glycemic trait in individual ancestries.

"This is important as increasingly healthcare is moving toward a more precise approach," Spracklen says. "Failing to account for genetic variation according to ancestry will impact our ability to accurately diagnose diabetes."

Source:
Journal reference:

Chen, J., et al. (2021) The trans-ancestral genomic architecture of glycemic traits. Nature Genetics. doi.org/10.1038/s41588-021-00852-9.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Global gap in diabetes prevalence and treatment has widened since 1990